Uncover the next big thing with 33 elite penny stocks that balance risk and reward.
To own Ingredion, you need to believe it can steadily compound earnings from specialty ingredients while managing headwinds in legacy sweeteners, tariffs, and emerging market volatility. The new CIBO regenerative agriculture partnership and board and CFO changes do not materially alter the near term focus on sustaining margins in Texture & Healthful Solutions or the key risk that price and mix pressure could intensify if input cost deflation persists.
The appointment of long-time executive Jason Payant as Interim CFO stands out here, given how central disciplined capital allocation and pricing decisions are to Ingredion’s effort to offset weaker industrial starch and HFCS demand with higher margin specialty products.
Yet investors should also be aware that the real test may come if currency shocks and softer volumes in key LATAM markets start to...
Read the full narrative on Ingredion (it's free!)
Ingredion's narrative projects $7.7 billion revenue and $791.0 million earnings by 2029. This requires 2.4% yearly revenue growth and about a $62 million earnings increase from $729.0 million today.
Uncover how Ingredion's forecasts yield a $127.43 fair value, a 13% upside to its current price.
Three members of the Simply Wall St Community currently see Ingredion’s fair value between US$127 and US$186, showing a wide spread of individual estimates. You can weigh those views against the risk that prolonged price and mix headwinds in core segments could challenge revenue resilience and consider what that might mean for Ingredion’s longer term performance.
Explore 3 other fair value estimates on Ingredion - why the stock might be worth just $127.43!
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com